NervGen Pharma Management
Management criteria checks 2/4
NervGen Pharma's CEO is Mike Kelly, appointed in Apr 2023, has a tenure of 1.58 years. total yearly compensation is CA$740.33K, comprised of 72.9% salary and 27.1% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth €257.15K. The average tenure of the management team and the board of directors is 1.6 years and 3.8 years respectively.
Key information
Mike Kelly
Chief executive officer
CA$740.3k
Total compensation
| CEO salary percentage | 72.9% |
| CEO tenure | 1.6yrs |
| CEO ownership | 0.2% |
| Management average tenure | 1.6yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -CA$24m |
| Jun 30 2024 | n/a | n/a | -CA$23m |
| Mar 31 2024 | n/a | n/a | -CA$20m |
| Dec 31 2023 | CA$740k | CA$540k | -CA$22m |
Compensation vs Market: Mike's total compensation ($USD529.66K) is about average for companies of similar size in the German market ($USD471.55K).
Compensation vs Earnings: Insufficient data to compare Mike's compensation with company performance.
CEO
Mike Kelly (58 yo)
1.6yrs
Tenure
CA$740,330
Compensation
Mr. Michael Kelly, also known as Mike, is an Independent Director of ARS Pharmaceuticals, Inc. and joined in May 2019. He serves as Chief Executive Officer, President and Director of NervGen Pharma Corp. s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.6yrs | CA$740.33k | 0.20% € 257.1k | |
| Co-Founder & Advisor | no data | CA$60.00k | no data | |
| Co-Founder & Independent Director | no data | no data | 1.6% € 2.0m | |
| CFO & Corporate Secretary | 4.8yrs | CA$431.63k | 0.22% € 278.3k | |
| Chief Medical Officer | 3.5yrs | CA$793.99k | no data | |
| Co-Founder & Advisor | no data | no data | no data | |
| Senior Vice President of Technical Operations | less than a year | no data | no data | |
| Senior Vice President of Program Management | less than a year | no data | no data |
1.6yrs
Average Tenure
61.5yo
Average Age
Experienced Management: 9UA's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.6yrs | CA$740.33k | 0.20% € 257.1k | |
| Co-Founder & Independent Director | 7.8yrs | no data | 1.6% € 2.0m | |
| Co-Founder & Advisor | no data | no data | no data | |
| Chairman | 3.2yrs | no data | 0.083% € 104.5k | |
| Independent Director | 6.5yrs | no data | 0.57% € 714.5k | |
| Independent Director | 4.1yrs | no data | 0.014% € 17.9k | |
| Member of Alzheimer's Disease Scientific Advisory Board | 3.8yrs | no data | no data | |
| Co-Inventor & Scientific Advisor | no data | no data | no data | |
| Member of Alzheimer's Disease Scientific Advisory Board | 3.8yrs | no data | no data | |
| Member of Alzheimer's Disease Scientific Advisory Board | 3.8yrs | no data | no data | |
| Advisor | 4.1yrs | no data | no data | |
| Member of Alzheimer's Disease Scientific Advisory Board | 3.8yrs | no data | no data |
3.8yrs
Average Tenure
66.5yo
Average Age
Experienced Board: 9UA's board of directors are considered experienced (3.8 years average tenure).